4//SEC Filing
Schadt Eric 4
Accession 0001209191-21-069329
CIK 0001818331other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 7:07 PM ET
Size
17.1 KB
Accession
0001209191-21-069329
Insider Transaction Report
Form 4
Schadt Eric
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Unit
2021-12-09+223,557→ 223,557 total→ Class A Common Stock (223,557 underlying) - Award
Restricted Stock Unit
2021-12-09+83,716→ 83,716 total→ Class A Common Stock (83,716 underlying) - Award
Restricted Stock Unit
2021-12-09+35,012→ 35,012 total→ Class A Common Stock (35,012 underlying) - Award
Restricted Stock Unit
2021-12-09+201,474→ 201,474 total→ Class A Common Stock (201,474 underlying) - Award
Restricted Stock Unit
2021-12-09+197,394→ 197,394 total→ Class A Common Stock (197,394 underlying)
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration, granted pursuant to the terms of that certain Agreement and Plan of Merger, dated as of February 9, 2021 (as amended, the "Merger Agreement"), by and among CM Life Sciences, Inc., S-IV Sub, Inc. and Mount Sinai Genomics, Inc. d/b/a Sema4. In addition, in the event that any similar RSUs are forfeited (for example, as a result of the recipient no longer being an employee of the Issuer), the Merger Agreement provides for the shares underlying such forfeited RSUs to become available for issuance to other RSU recipients. Therefore, each RSU also represents to right to receive additional shares of the Issuer's Class A Common Stock from this "forfeiture pool". The number of shares of the Issuer's Class A Common Stock that may be issued to the Reporting Person pursuant to the "forfeiture pool" is not determinable at this time.
- [F2][cont'd from footnote 1] Any shares of the Issuer's Class A Common Stock ultimately issued to the Reporting Person in respect of each RSU will be reported in a subsequent filing.
- [F3]The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement. The service requirement is deemed satisfied as of the grant date.
- [F4]The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement. The service requirement is deemed satisfied as of the grant date with respect to 12,254 of the RSUs, and will be satisfied with respect to the remainder of the RSUs over 4 vesting periods, subject to the Reporting Person's continued service to the Issuer on each service-based vesting date.
- [F5]The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement. The service requirement is deemed satisfied as of the grant date with respect to 54,532 of the RSUs, and will be satisfied with respect to the remainder of the RSUs over 5 semi-annual periods, subject to the Reporting Person's continued service to the Issuer on each service-based vesting date.
- [F6]The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement. The service requirement is deemed satisfied as of the grant date with respect to 100,737 of the RSUs, and will be satisfied with respect to the remainder of the RSUs over 8 quarterly periods, subject to the Reporting Person's continued service to the Issuer on each service-based vesting date.
Documents
Issuer
Sema4 Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001873468
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 7:07 PM ET
- Size
- 17.1 KB